Lupin (NSE:LUPIN) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LUPIN Lupin Ltd NSE:LUPIN
89 GF Score
Price ₹2,410.00
GF Value ₹2,465.16
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Lupin Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

NSE:LUPIN
89GF Score
Lupin Ltd NSE:LUPIN
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lupin (NSE:LUPIN) Overvalued in 2026?

Based on GuruFocus' analysis, Lupin stock appears to be undervalued. The current stock price of ₹2,410.00 is trading 2.2% below its estimated GF Value™ of ₹2,465.16. GuruFocus considers Lupin to be Fairly Valued.

Key valuation signals for NSE:LUPIN:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹2,465.16 vs. price of ₹2,410.00 (2.2% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the NSE:LUPIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lupin Business Description

Other Exchanges 500257:India
Address Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400055
Lupin Ltd is a specialty and generic drug manufacturing company. The company produces, develops, and markets branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) globally. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, GastroIntestinal, and other drug therapy segments. The operations of the company are limited to the segments, namely pharmaceuticals which derives key revenue, and others. It also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India, and other countries.
89GF Score

Get the complete analysis for NSE:LUPIN

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,410.00
Price
₹2,465.16
GF Value